| TIRVAYA OYSTER POINT PHARMA INC.
2052237 10 Aug 2020 | on 31 Dec 1969 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for the treatment of dry eye disease; pharmaceutical preparations for the treatment of neurotropic keratitis; pharmaceutical preparations for the treatment of ophthalmological diseases; nasal spray preparations; pharmaceutical preparations in the form of nasal sprays for the treatment of ophthalmological diseases. | | | TIRVEO ELI LILLY AND COMPANY
1510299 06 Jan 2011 | on 25 Jan 2017 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations namely, pharmaceutical preparations for the treatment of alcohol use disorders, anxiety, bone and skeletal diseases and disorders namely osteoporosis, osteoarthritis; fracture healing, bone frailty due to extended ventilator use, hip &/or knee replacement surgery, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, arthritis, bursitis, tendonitis, osteonecrosis, and Paget's disease, blood disorders, cancer, cardiovascular diseases, cholesterol disorders, central nervous system diseases and disorders namely anxiety disorders, depression, bipolar depression, bipolar disorder, treatment resistant depression, schizophrenia, cognitive impairment associated with schizophrenia, diabetes, endocrine diseases and disorders namely Type 2 Diabetes Mellitus, Type 1 Diabetes Mellitus, gastrointestinal diseases and disorders, hormonal diseases and disorders namely Vasomotor symptoms/hot flashes, inflammation and inflammatory diseases and disorders, liver diseases and disorders, kidney diseases and disorders, neurodegenerative diseases and disorders, neurological disorders namely Alzheimer's disease, mild cognitive impairment, Parkinson's disease, multiple sclerosis, obesity, pain, reproductive system diseases and disorders namely uterine fibroids, endometriosis, benign prostatic hyperplasia, polycystic ovarian syndrome, urological disorders, dyslipidemia, sleep disorders, migraines, metabolic diseases and disorders namely metabolic syndrome, antipsychotics, antidepressants, anxiety spectrum disorders, atherosclerosis, Alzheimer's, pharmaceutical preparations for use in the treatment of diabetes; pharmaceutical preparations for use in the treatment of rheumatoid arthritis; pharmaceutical preparations for use in the treatment of Crohn's disease, systemic lupus erythematosus, and ankylosing spondylitis disease; pharmaceutical preparations for use in the treatment of psoriasis and psoriatic arthritis; pharmaceutical preparations for use in the treatment of autoimmune disorders. | |